Discontinued — last reported Q4 '25
Over 4 years (FY 2021 to FY 2025), Pharma Solutions — Goodwill shows a downward trend with a -100.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A stable or growing balance indicates successful integration and value retention, while a declining balance suggests impairment risks.
The intangible asset value recorded when the Pharma Solutions segment was acquired for a price exceeding the fair value...
Standard balance sheet item for companies that have grown through acquisition.
iff_segment_pharma_solutions_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.69B | $1.54B | $1.28B | $1.27B | $1.24B | $1.19B | $1.24B | $1.25B | $1.26B | $1.24B | $1.27B | $1.25B | $73.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -8.9% | -16.7% | -1.0% | -2.7% | -3.8% | +4.3% | +1.1% | +0.4% | -1.7% | +2.3% | -1.2% | -94.2% | -100.0% | — | — | — | — | — |
| YoY Change | — | — | — | — | -26.9% | -22.8% | -3.4% | -1.3% | +1.9% | +4.0% | +2.1% | -0.2% | -94.2% | -100.0% | -100.0% | -100.0% | -100.0% | — | — |